| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Proceeds from issuance of common stock through private placement, net | - | 0 |
| Net cash provided by financing activities | 670 | 653 |
| Net (decrease) increase in cash, cash equivalents, and restricted cash | -32,584 | -10,207 |
| Cash and cash equivalents at beginning of period | 126,406 | - |
| Cash and cash equivalents at end of period | 93,822 | - |
Relay Therapeutics, Inc. (RLAY)
Relay Therapeutics, Inc. (RLAY)